Transdermal drug delivery microneedle patch
By opening a drug storage groove on the microneedle and using a combined structure of tearing mucosa and solid microneedle, the problem of insufficient drug loading of microneedle is solved, efficient transdermal administration is achieved, and the patient's pain and puncture are reduced. The number of times simplifies design and is easy to use and promote.
Patent Information
- Application Number
- CN202323014039.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-08
- Publication Date
- 2024-11-01
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing microneedle loading volume is low, resulting in the need for multiple injections for skin treatment with severe injuries, which increases the patient's pain, and the existing design is complex and inconvenient for use.
The drug storage groove is opened on the microneedle to increase the drug load, and the combination of the mucosa and solid microneedle can achieve efficient transdermal administration of the drug and reduce the number of punctures.
By increasing the loading volume, multiple injections are avoided, the patient's pain is reduced, and the structure is simplified for ease of use and promotion.
Smart Images

Figure CN221932852U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to a microneedle patch for transdermal drug delivery, which can carry more drugs and belongs to the field of medical technology. In particular, it relates to a microneedle patch with drug storage grooves on the microneedles, which can increase the drug loading capacity, avoid multiple injections, and reduce the pain of patients. Background Art
[0002] Microneedles are a minimally invasive drug delivery method that can penetrate the epidermis into the dermis and form microchannels on the skin surface to help drugs enter the skin. Their length is not enough to reach the subcutaneous pain nerves, and the formed microchannels can also recover within a few hours. They are minimally invasive, painless, and easy to use, so they are popular. At present, microneedles have been widely studied for the delivery of a variety of drugs, including small molecules, proteins, nucleic acids, vaccines, and nanoparticles. Microneedles used for transdermal drug delivery are usually conical or quadrangular pyramidal, with the needle tip used to puncture the skin and the needle body used to load drugs. Since the microneedles are very small and the drug loading capacity of the needle body is very low, multiple drug punctures are required for the treatment of severely injured skin, which increases the pain of the patient during puncture. How to increase the drug loading is one of the main factors restricting its application. The drug loading is usually increased by increasing the height of the microneedles and the density of the microneedle array, but the increase in the density of the microneedles makes it more difficult to insert the microneedles into the skin, and more force is required to make the needle tip enter the skin. The increase in the height of the microneedles will increase the depth of the microneedles puncturing the skin, increasing the pain of the patients.
[0003] Publication No. CN202211334161.5 discloses a microneedle for improving drug utilization, the microneedle comprises a substrate and a plurality of needle bodies arranged in an array on the substrate; the needle body comprises a base, a needle tip, and a supporting connection portion connecting the base and the needle tip; the base is a truncated cone, the bottom inclination angle of the truncated cone is 15° to 50°; the needle tip is a cone, the top angle of the cone is 15° to 40°; the side of the supporting connection portion is a concave curved surface. The microneedle needs to set the bottom inclination angle of the truncated cone and the top angle of the needle tip when designing, the structure is complex, inconvenient to use, and only improves the utilization rate of the drug, but the needle body has limited drug storage and does not increase the drug loading. For skin treatment with severe injuries, multiple drug application and puncture are still required during treatment, which cannot reduce the patient's pain. Utility Model Content
[0004] In order to improve the above situation, the utility model provides a transdermal drug delivery microneedle patch that can carry more drugs. By opening drug storage grooves on the microneedles, the drug loading capacity of the microneedles can be increased, multiple injections can be avoided, and the pain of the patient can be reduced.
[0005] The utility model transdermal drug delivery microneedle patch is realized as follows: the utility model transdermal drug delivery microneedle patch is composed of a microneedle patch, a tearing mucosa, a solid microneedle and a drug storage groove.
[0006] Tear off the mucous membrane and place it on one side of the microneedle patch.
[0007] Solid microneedles are placed on the other side of the microneedle patch.
[0008] Preferably, the width of the tearing mucosa is greater than the width of the microneedle patch.
[0009] Preferably, there are a plurality of solid microneedles, and the plurality of solid microneedles are evenly distributed along the microneedle patch.
[0010] The solid microneedle is a cone structure, and a drug storage groove is opened on the side of the solid microneedle.
[0011] Preferably, there are a plurality of drug storage grooves, and the plurality of drug storage grooves are arranged equidistantly in a spiral along the side of the solid microneedle.
[0012] Preferably, the width of each of the drug storage grooves decreases gradually from one end to the other end in an arc shape, and the depth of each of the drug storage grooves decreases gradually from one end to the other end.
[0013] Preferably, the depth of the drug storage groove is less than one fifth of the diameter of the solid microneedle;
[0014] Furthermore, the medicine storage groove is provided with medicine retention vertical lines.
[0015] Preferably, there are a plurality of the drug-retaining vertical lines, and the plurality of the drug-retaining vertical lines are arranged equidistantly in a spiral along the wall of the drug-retaining groove;
[0016] Furthermore, the medicine storage groove is provided with medicine retaining oblique lines.
[0017] Preferably, each of the drug storage grooves has two groups of drug-retaining twills, each group of the drug-retaining twills has a plurality of drug-retaining twills, and the two groups of the drug-retaining twills are symmetrically arranged with the center line of the drug storage groove as the starting point. Beneficial Effects
[0018] 1. By opening drug storage grooves on the microneedles, the drug loading capacity of the microneedles can be increased, multiple injections can be avoided, and the pain of the patients can be reduced.
[0019] 2. Simple structure, convenient and practical.
[0020] 3. Low cost and easy to promote. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is a schematic diagram of the structure of the transdermal drug delivery microneedle patch of the utility model;
[0022] Figure 2 This is a schematic diagram of the structure of the microneedle patch for transdermal drug delivery of the utility model, which only shows the structure of the microneedle patch and the solid microneedle;
[0023] Figure 3 It is a three-dimensional structural diagram of the solid microneedles of the transdermal drug delivery microneedle patch of the utility model;
[0024] Figure 4 It is a three-dimensional structural diagram of Example 2 of the transdermal drug delivery microneedle patch of the utility model;
[0025] Figure 5 It is a three-dimensional structural diagram of Example 3 of the transdermal drug delivery microneedle patch of the utility model;
[0026] In the attached figure
[0027] Among them: microneedle patch 1, tearing mucosa 2, solid microneedle 3, drug storage groove 4, drug retention vertical line 5, drug retention oblique line 6 DETAILED DESCRIPTION
[0028] Embodiment 1:
[0029] The utility model transdermal drug delivery microneedle patch 1 is realized as follows: The utility model transdermal drug delivery microneedle patch 1 is composed of a microneedle patch 1, a tearing mucosa 2, a solid microneedle 3 and a drug storage groove 4.
[0030] The peeled mucosa 2 is placed on one side of the microneedle patch 1.
[0031] The solid microneedle 3 is placed on the other side of the microneedle patch 1.
[0032] Preferably, the microneedle patch 1 is a rectangular sheet structure, a circular sheet structure or an irregular sheet structure.
[0033] Preferably, the tear-off adhesive film 2 is integrally formed with the microneedle patch 1, and the width of the tear-off adhesive film 2 is smaller than the width of the microneedle patch 1.
[0034] Preferably, there are a plurality of solid microneedles 3, and the plurality of solid microneedles 3 are evenly distributed along the microneedle patch 1.
[0035] Preferably, the microneedle patch 1 is a combination of a rectangular sheet structure, a circular sheet structure, a diamond sheet structure or a triangular sheet structure.
[0036] The solid microneedle 3 is a conical structure, and a drug storage groove 4 is opened on the side of the solid microneedle 3.
[0037] Preferably, there are a plurality of drug storage grooves 4, and the plurality of drug storage grooves 4 are arranged equidistantly in a spiral along the side of the solid microneedle 3.
[0038] Preferably, the width of each of the drug storage grooves 4 decreases gradually from one end to the other end in an arc shape, and the depth of each of the drug storage grooves 4 decreases gradually from one end to the other end.
[0039] Preferably, the depth of the drug storage groove 4 is less than one fifth of the diameter of the solid microneedle 3;
[0040] When in use, first soak the solid microneedles 3 in the medicine so that the medicine adheres to the surface of the solid microneedles 3 and the medicine storage grooves 4, then tear off the protective film on the tear-off mucosa 2, stick the microneedle patch 1 on the patient's wound, and the solid microneedles 3 pierce the patient's skin, and the medicine stored in the medicine storage grooves 4 is sent into the patient's body through the skin to achieve treatment;
[0041] Embodiment 2:
[0042] The difference between this embodiment and embodiment 1 is that: the drug storage groove 4 is provided with a drug retention vertical line 5, and there are a plurality of the drug retention vertical lines 5, and the plurality of the drug retention vertical lines 5 are arranged equidistantly in a spiral along the groove wall of the drug storage groove 4; when in use, the drug retention vertical lines 5 can increase the drug loading capacity of the microneedle, avoid multiple injections, and reduce the pain of the patient;
[0043] Embodiment 3:
[0044] The difference between this embodiment and embodiment 1 is that: the drug storage groove 4 is provided with a drug retention twill 6, each of the drug storage grooves 4 has two groups of the drug retention twill 6, each group of the drug retention twill 6 has a plurality of drug retention twills, and the two groups of the drug retention twills 6 are symmetrically and equidistantly arranged with the center line of the drug storage groove 4 as the starting point; when in use, the drug retention twill 6 can increase the drug loading capacity of the microneedle, avoid multiple injections, and reduce the pain of the patient;
[0045] The design that the width of the tearing mucosa 2 is greater than the width of the microneedle patch 1 can make the solid microneedles 3 closely attached to the patient's skin through the microneedle patch 1, preventing them from falling and affecting the treatment, and reducing the pain caused by multiple medication punctures;
[0046] There are multiple drug storage grooves 4, and the multiple drug storage grooves 4 are arranged in a spiral and equidistant manner along the side of the solid microneedle 3, which can increase the storage capacity of the drug and reduce the pain caused by multiple drug punctures;
[0047] The width of each of the drug storage grooves 4 decreases gradually from one end to the other end in an arc shape, and the depth of each of the drug storage grooves 4 decreases gradually from one end to the other end, which can increase the contact surface between the drug stored in the drug storage groove 4 and the skin, and increase the absorption effect of the skin on the drug;
[0048] The depth of the drug storage groove 4 is less than one fifth of the diameter of the solid microneedle 3, which can prevent the skin from not being able to contact the drug, resulting in a reduction in the therapeutic effect;
[0049] The purpose of increasing the drug loading capacity of the microneedle by providing the drug storage groove 4 on the microneedle, avoiding multiple injections, and reducing the pain of the patient is achieved.
[0050] It should be noted that, unless otherwise clearly specified and limited, the terms "placed", "connected" and "connected" should be understood in a broad sense, for example, it can be a fixed connection method such as a folding connection, a rivet connection, a pin connection, a bonding connection and a welding connection, or a detachable connection method such as a threaded connection, a snap connection and a hinge connection, or an integral connection, or an electrical connection, or a direct connection, or an indirect connection through an intermediate medium, or the internal connection of two components. For ordinary technicians in this field, the specific meanings of the above terms in this utility model can be understood according to specific circumstances.
[0051] It should be further pointed out that, when describing the above specific embodiments, for the sake of simplicity and clarity, only the differences between the above specific embodiments are described, but those skilled in the art should know that the above specific embodiments themselves are also independent technical solutions.
Claims
1. A transdermal drug delivery microneedle patch, characterized in that: The invention is composed of a microneedle patch, a tear-off mucosa, a solid microneedle and a drug storage groove. The tear-off mucosa is placed on one side of the microneedle patch, and the solid microneedle is placed on the other side of the microneedle patch. The solid microneedle is a cone structure, and a drug storage groove is opened on the side of the solid microneedle.
2. A transdermal drug delivery microneedle patch according to claim 1, characterized in that The medicine storage groove is provided with medicine retention vertical lines, and there are a plurality of the medicine retention vertical lines, which are arranged in a spiral and equidistant manner along the wall of the medicine storage groove.
3. A transdermal drug delivery microneedle patch according to claim 1, characterized in that The drug storage groove is provided with drug retention twills, each of the drug storage grooves has two groups of drug retention twills, each group of drug retention twills has a plurality of drug retention twills, and the two groups of drug retention twills are symmetrically arranged with the center line of the drug storage groove as the starting point.
4. A transdermal drug delivery microneedle patch according to claim 1, characterized in that The width of the tearing mucosa is greater than the width of the microneedle patch.
5. A transdermal drug delivery microneedle patch according to claim 1, characterized in that There are a plurality of solid microneedles.
6. A transdermal drug delivery microneedle patch according to claim 1 or 5, characterized in that The plurality of solid microneedles are evenly distributed along the microneedle patch.
7. A transdermal drug delivery microneedle patch according to claim 1, characterized in that The width of each drug storage groove decreases gradually from one end to the other end in an arc shape.
8. A transdermal drug delivery microneedle patch according to claim 1 or 7, characterized in that The depth of each drug storage groove gradually decreases from one end to the other end.
9. A transdermal drug delivery microneedle patch according to claim 8, characterized in that The depth of the drug storage groove is less than one fifth of the diameter of the solid microneedle.
10. A transdermal drug delivery microneedle patch according to claim 1 or 9, characterized in that There are a plurality of drug storage grooves, and the plurality of drug storage grooves are arranged equidistantly in a spiral along the side surface of the solid microneedle.
